Questions? Call 888-624-8373

Read this book online, free! Click here to proceed to linked table of contents

New Treatments for Addiction:

Behavioral, Ethical, Legal, and Social Questions

Book Cover

Status: Available Now

Size: 320 pages, 6x9

Publication Year:2004

PAPERBACK + PDF$57.50

Print List Price Your Price  
Order online and save 10%
PAPERBACK
ISBN-10: 0-309-09128-4
ISBN-13: 978-0-309-09128-2
$49.00 $44.10 Add to Cart
PDF   Your Price  
PDF Download [6.7 MB]   $37.50 Add to Cart
PDF Chapters   $3.60 Select
PDF? What am I buying?

Authors:
Henrick J. Harwood and Tracy G. Myers, Editors, Committee on Immunotherapies and Sustained-Release Formulations for Treating Drug Addiction, National Research Council
Authoring Organizations

Description:

New and improved therapies to treat and protect against drug dependence and abuse are urgently needed. In the United States alone about 50 million people regularly smoke tobacco and another 5 million are addicted to other drugs. In a given ...
Read More


Paste into your Web page:

Preview
Free Resources
Read

Full Text
Jump to this book's table of contents to begin reading online for free.

Research Tools

Web Search Builder
Use this book's key terms to search within this book, across our collection, or across the Web.

Reference Finder
Paste in your own text to find books that relate to your topic.

Download Free

PDF Summary
Download executive summary in PDF.

Rights & Permissions

Reprint Permission
Request permission to license or reprint the book's content through Copyright Clearance Center's Rightslink.

Request Permission to Distribute a PDF

Request Translation Rights

Questions About Rights and Permissions?

Table of Contents
Select a link below to start reading online free!
Front Matter i-xiv  
Executive Summary 1-6 (skim)
1 Introduction and Background 7-15 (skim)
2 Clinical Trials 16-22 (skim)
3 Treatment, Financing, and Costs 23-36 (skim)
4 Behavioral Responses and Consent 37-53 (skim)
References 54-60 (skim)
Appendix A: Vaccines and Depot Medications for Drug Addiction: Rationale, Mechanisms of Action, and Treatment Implications 61-97 (skim)
Appendix B: What Will We Learn from the FDA Clinical Trials Process and What Will We Still Want to Know About Immunotherapies and Depot Medications to Treat Drug Dependence? 98-124 (skim)
Appendix C: Putting Addiction Treatment Medications to Use: Lessons Learned 125-139 (skim)
Appendix D: Adoption of Drug Abuse Treatment Technology in Speciality and Primary Care Settings 140-172 (skim)
Appendix E: The Use of Immunotherapies and Sustained-Release Formulations in the Treatment of Drug Addiction: Will Current Law Support Coercion? 173-187 (skim)
Appendix F: Ethical Issues in Immunotherapies and Depot Mechanisms for Substance Abuse 188-212 (skim)
Appendix G: Costs and Benefits of Immunotherapies or Depot Medications for the Treatment of Drug Abuse 213-240 (skim)
Appendix H: Anticipating Unintended Consequences of Vaccine-Like Immunotherapies for Addictive Drug Use 241-275 (skim)
Appendix I: Vaccines and Immunotherapies to Control Addiction in Minors: The Legal Framework 276-299 (skim)
Appendix J: Biographical Sketches of Committee Members and Staff 300-306 (skim)

Description

New and improved therapies to treat and protect against drug dependence and abuse are urgently needed. In the United States alone about 50 million people regularly smoke tobacco and another 5 million are addicted to other drugs. In a given year, millions of these individuals attempt with or without medical assistance to quit using drugs, though relapse remains the norm. Furthermore, each year several million teenagers start smoking and nearly as many take illicit drugs for the first time. Research is advancing on promising new means of treating drug addiction using immunotherapies and sustained-release (depot) medications. The aim of this research is to develop medications that can block or significantly attenuate the psychoactive effects of such drugs as cocaine, nicotine, heroin, phencyclidine, and methamphetamine for weeks or months at a time. This represents a fundamentally new therapeutic approach that shows promise for treating drug addiction problems that were difficult to treat in the past. Despite their potential benefits, however, several characteristics of these new methods pose distinct behavioral, ethical, legal, and social challenges that require careful scrutiny. Such issues can be considered unique aspects of safety and efficacy that are fundamentally related to the distinct nature and properties of these new types of medications.

About the PDF: What am I Buying?

About Our PDFs

This book can be purchased as a computer file. The format of the file is called a "PDF". To open, view and print the file, you must have third party software (e.g. Adobe Reader or XPDF) installed on your computer.

Benefits of Buying a PDF

  • Instant. Buy it, download it immediately, and start reading.
  • Convenient. Download it to your laptop and read it whenever, wherever.
  • Searchable. Search for any word or phrase.

What are my options?

If you want ... Then ...
... only a portion of the book... select a PDF Chapter
... a computer file containing the entire book ... buy a PDF
... to read the book immediately and also own a copy for your bookshelf ... buy the bundle
... a copy for your bookshelf ... buy the book

Will my PDF be emailed to me?

No. After buying the PDF, we will email you instructions on how to download the file from our Web site. The PDF file will not be emailed to you.

See our Frequently Asked Questions for more information including:

Search This Book

»Find more like this book

SIGN UP FOR...

New Title Emails
Read about the newest releases and receive special offers.



[ Top of Page ] [ Home ] [ Contact Us ] [ Help ] [ The National Academies Home ]